MX2016013201A - Composicion y metodo para producir una nanoformulacion de bioactivos insolubles en agua en una base acuosa. - Google Patents
Composicion y metodo para producir una nanoformulacion de bioactivos insolubles en agua en una base acuosa.Info
- Publication number
- MX2016013201A MX2016013201A MX2016013201A MX2016013201A MX2016013201A MX 2016013201 A MX2016013201 A MX 2016013201A MX 2016013201 A MX2016013201 A MX 2016013201A MX 2016013201 A MX2016013201 A MX 2016013201A MX 2016013201 A MX2016013201 A MX 2016013201A
- Authority
- MX
- Mexico
- Prior art keywords
- nanodispersion
- nanoformulation
- bioactives
- producing
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dispersion Chemistry (AREA)
- Biochemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Colloid Chemistry (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1872CH2014 IN2014CH01872A (cg-RX-API-DMAC7.html) | 2014-04-09 | 2015-04-08 | |
| PCT/IB2015/052541 WO2015155703A2 (en) | 2014-04-09 | 2015-04-08 | Composition and method of producing nanoformulation of water insoluble bioactives in aqueous base |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2016013201A true MX2016013201A (es) | 2017-04-25 |
Family
ID=54288490
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016013201A MX2016013201A (es) | 2014-04-09 | 2015-04-08 | Composicion y metodo para producir una nanoformulacion de bioactivos insolubles en agua en una base acuosa. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11458096B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3129002A4 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2015246030B2 (cg-RX-API-DMAC7.html) |
| EA (1) | EA038458B1 (cg-RX-API-DMAC7.html) |
| IN (1) | IN2014CH01872A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2016013201A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2015155703A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106470548B (zh) | 2014-04-30 | 2020-06-30 | 玛托克控股有限公司 | 抗微生物组合物 |
| GB201716986D0 (en) | 2017-10-16 | 2017-11-29 | Matoke Holdings Ltd | Antimicrobial compositions |
| FR3075661A1 (fr) * | 2017-12-21 | 2019-06-28 | Coatex | Emulsion submicronique |
| EP3731801B1 (en) * | 2017-12-29 | 2022-03-09 | L'oreal | Compositions for altering the color of hair |
| WO2019175830A1 (en) * | 2018-03-14 | 2019-09-19 | Azista Industries Pvt Ltd | Cholecalciferol nanoemulsion formulations and methods for producing same |
| WO2023118928A1 (en) | 2021-12-21 | 2023-06-29 | Opella Healthcare Group Sas | Stable nanoformulation for lipophilic actives, oral dosage form and process for its preparation |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0580778B1 (en) * | 1991-04-19 | 1999-08-11 | LDS Technologies, Inc. | Convertible microemulsion formulations |
| CA2091152C (en) | 1993-03-05 | 2005-05-03 | Kirsten Westesen | Solid lipid particles, particles of bioactive agents and methods for the manfuacture and use thereof |
| US5518738A (en) | 1995-02-09 | 1996-05-21 | Nanosystem L.L.C. | Nanoparticulate nsaid compositions |
| WO1997010814A1 (en) * | 1995-09-18 | 1997-03-27 | Vesifact Ag | Propofol nanodispersions |
| DE19642359A1 (de) | 1996-10-14 | 1998-04-16 | Basf Ag | Stabile Emulsionen und Trockenpulver von Mischungen fettlöslicher Vitamine, deren Herstellung und Verwendung |
| US5994414A (en) | 1997-04-28 | 1999-11-30 | Avon Products, Inc. | Water-thin emulsion formed by high pressure homogenization process |
| DK1249230T3 (da) * | 2001-04-12 | 2004-03-15 | Vesifact Ag | Mikroemulsion-prækoncentrater og mikroemulsioner indeholdende coenzym Q10 |
| US6780324B2 (en) * | 2002-03-18 | 2004-08-24 | Labopharm, Inc. | Preparation of sterile stabilized nanodispersions |
| CN1655762B (zh) | 2002-06-17 | 2010-05-26 | 塔罗制药美国公司 | 布洛芬混悬剂 |
| US8628690B2 (en) | 2004-02-23 | 2014-01-14 | The Texas A&M University System | Nanoemulsion compositions and methods of use thereof |
| EP1597973A1 (en) | 2004-05-18 | 2005-11-23 | Nestec S.A. | Oil-in-water emulsion for delivery |
| US20060051462A1 (en) * | 2004-09-03 | 2006-03-09 | Wang Jimmy X | Self emulsifying compositions for delivering lipophilic coenzyme Q10 and other dietary ingredients |
| WO2008045107A2 (en) | 2005-12-01 | 2008-04-17 | University Of Massachusetts Lowell | Botulinum nanoemulsions |
| CN101011355B (zh) * | 2006-02-01 | 2013-01-02 | 陈献 | 经维生素e琥珀酸酯稳定的医药组合物、其制备及用途 |
| WO2007103294A2 (en) | 2006-03-07 | 2007-09-13 | Novavax, Inc. | Nanoemulsions of poorly soluble pharmaceutical active ingredients and methods of making the same |
| EP1938801A1 (en) | 2006-12-22 | 2008-07-02 | Biofrontera Bioscience GmbH | Nanoemulsion |
| WO2009070642A1 (en) * | 2007-11-28 | 2009-06-04 | Medimmune, Llc | Protein formulation |
| WO2009067734A1 (en) | 2007-11-28 | 2009-06-04 | Commonwealth Scientific And Industrial Research Organisation | Nanoemulsions |
| EP2201937A1 (en) | 2008-12-23 | 2010-06-30 | Teva Pharmaceutical Industries Ltd. | Formulations comprising vitamin D or derivatives thereof |
| JP6176894B2 (ja) | 2009-03-09 | 2017-08-09 | プロノヴァ・バイオファーマ・ノルゲ・アーエス | 脂肪酸油混合物及び界面活性剤を含む組成物、並びにその方法及び使用 |
| ES2530049T3 (es) * | 2009-05-18 | 2015-02-26 | Sigmoid Pharma Limited | Composición que comprende gotas de aceite |
| CN102802624A (zh) * | 2009-06-19 | 2012-11-28 | 太阳医药高级研发有限公司 | 药物的纳米分散体以及它的制备方法 |
| CN102933200B (zh) * | 2009-12-18 | 2015-11-25 | 莱迪杜德制药公司 | 包含磷脂的单相凝胶组合物 |
| EP3366280A1 (en) * | 2010-03-12 | 2018-08-29 | Berg LLC | Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof |
| US20110229516A1 (en) * | 2010-03-18 | 2011-09-22 | The Clorox Company | Adjuvant phase inversion concentrated nanoemulsion compositions |
| SE536746C2 (sv) | 2010-05-12 | 2014-07-08 | Stora Enso Oyj | En komposition innehållande mikrofibrillerad cellulosa och en process för tillverkning av en komposition |
| US8835509B2 (en) | 2010-05-31 | 2014-09-16 | Arbro Pharmaceuticals Ltd. | Self emulsifying drug delivery system for a curcuminoid based composition |
| JP2013537185A (ja) | 2010-09-08 | 2013-09-30 | プロノヴァ・バイオファーマ・ノルゲ・アーエス | 遊離酸の形のｅｐａおよびｄｈａを含む脂肪酸油混合物と界面活性剤とスタチンとを含む組成物 |
| WO2013008083A1 (en) | 2011-07-13 | 2013-01-17 | National Institute Of Pharmaceutical Education And Research (Niper) | Pharmaceutical composition for enhancing anticancer efficacy of tamoxifen |
| NZ596015A (en) | 2011-10-26 | 2014-04-30 | Anzamed Internat Ltd | Method and composition for the treatment of pain and/or inflammation |
| GB201204377D0 (en) | 2012-03-13 | 2012-04-25 | Givaudan Sa | Composition |
-
2015
- 2015-04-08 IN IN1872CH2014 patent/IN2014CH01872A/en unknown
- 2015-04-08 EA EA201692044A patent/EA038458B1/ru unknown
- 2015-04-08 AU AU2015246030A patent/AU2015246030B2/en active Active
- 2015-04-08 EP EP15777362.3A patent/EP3129002A4/en active Pending
- 2015-04-08 WO PCT/IB2015/052541 patent/WO2015155703A2/en not_active Ceased
- 2015-04-08 MX MX2016013201A patent/MX2016013201A/es active IP Right Grant
- 2015-04-08 US US15/302,495 patent/US11458096B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3129002A4 (en) | 2017-11-08 |
| EP3129002A2 (en) | 2017-02-15 |
| US11458096B2 (en) | 2022-10-04 |
| US20180177723A1 (en) | 2018-06-28 |
| IN2014CH01872A (cg-RX-API-DMAC7.html) | 2015-05-08 |
| WO2015155703A3 (en) | 2015-12-30 |
| WO2015155703A2 (en) | 2015-10-15 |
| EA201692044A1 (ru) | 2017-04-28 |
| EA038458B1 (ru) | 2021-08-31 |
| AU2015246030A1 (en) | 2016-11-24 |
| AU2015246030B2 (en) | 2020-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2016013201A (es) | Composicion y metodo para producir una nanoformulacion de bioactivos insolubles en agua en una base acuosa. | |
| MX2021010105A (es) | Particulas de nanoalumbre que contienen un agente de dimensionamiento. | |
| EP3267964A4 (en) | Peg free stable low viscosity oil-in-water emulsion and use thereof | |
| HK1225613A1 (zh) | 赖谷胰岛素的稳定制剂 | |
| EP3215806A4 (en) | 3d imaging, ranging, and/or tracking using active illumination and point spread function engineering | |
| MX390001B (es) | Composiciones de bebida lista para beber estables que comprende agentes activos lipofilos. | |
| PL2968306T3 (pl) | Podawanie mononukleotydu nikotynamidu do leczenia zespołu suchego oka | |
| MX2015013894A (es) | Composiciones de nanoparticulas novedosas. | |
| JP2015110565A5 (cg-RX-API-DMAC7.html) | ||
| MX2015010312A (es) | Metodos para tratamiento del melanoma. | |
| CL2016002308A1 (es) | Nanopartículas que comprenden un ácido hidrofóbico, un copolímero de dibloque pla-peg o plga-peg, y 1 -4- 4-dimetilamino piperidin-1-il carbonilfenil-3-4-4,6-dimorfolin-4-il-1,3,5-triazin-2-ilfenilurea composición farmacética proceso de preparación y uso para tratar cáncer | |
| IL254813B (en) | Sustained-release injectable formulations containing isoxazoline active agent and methods and uses thereof | |
| MX2015012667A (es) | Pigmento de dioxido de titanio y metodo de fabricacion. | |
| CL2015000502A1 (es) | Nanoparticula polimerica de finasterida, suspension acuosa conteniendo a la misma, composicion para tratamiento de alopecia, proceso de preparacion de dicha composicion, y su uso. | |
| BR112018070960A2 (pt) | formulação parenteral de nimodipina estável | |
| MX2016009577A (es) | Composicion acuosa para recubrimiento de superficies y particulas modificadas. | |
| CL2017001483A1 (es) | Formulación de relación fija de insulina glargina/lixisenatida | |
| MX2019010852A (es) | Nanoparticulas a base de lipidos con estabilidad mejorada. | |
| ZA201601668B (en) | Cosmetic composition comprising a sulphonic polymer, a hydrophobic polysaccharide and a silicone surfactant | |
| MX2018000637A (es) | Nanocápsula para la administración de un compuesto lipófilo y proceso de preparación de la misma. | |
| MX385886B (es) | Macromoleculas estrellas compatibles con tensoactivos. | |
| IL266279B1 (en) | Stable aqueous capsaicin injectable formuatlions and medical uses thereof | |
| AR101581A1 (es) | Composición de colutorio | |
| MX2018005085A (es) | Nanoparticulas terapeuticas que comprenden un agente terapeutico y metodos de fabricacion y uso de las mismas. | |
| MX2016015208A (es) | Nanoparticulas de clevidipina y composiciones farmaceuticas que las contienen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| PD | Change of proprietorship |
Owner name: PULSE PHARMACEUTICALS PVT LTD |